C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2007
11/28/2007	EP1858850A2 Process for the preparation of opioid modulators
11/28/2007	EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007	CN101078129A Formiate ion liquid compound and its preparing method and application
11/28/2007	CN101077863A Modified method for chemically synthesizing N-acetyl-L-carnosine
11/28/2007	CN101077862A D-glucose-L-amino acid, preparation method and application thereof
11/28/2007	CN100351238C New derivatives of erythromycin, their preparation process and their use as medicaments
11/28/2007	CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007	US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007	US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007	CA2374251C Preparation and use of ionic liquids in microwave-assisted chemical transformations
11/22/2007	WO2007133616A2 Biodegradable water soluble polymers
11/22/2007	WO2007132475A1 Selective tr-beta 1 agonist
11/22/2007	WO2007131955A1 Porous metal organic framework based on pyrroles and pyridinones
11/22/2007	WO2007131498A2 Salts consisting of pentafluorphenylimide anions and their use as ionic liquids
11/22/2007	WO2007078990A3 Modified lysine-mimetic compounds
11/22/2007	US20070270472 Amino, Amino Acid or Peptide Conjugates of Retinoic Acid
11/22/2007	US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007	US20070270442 Combination of a Cdk Inhibitor and Cs-682 or a Metabolite Thereof
11/22/2007	US20070270435 Novel Compounds
11/22/2007	US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007	US20070269664 Gas Barrier Laminated Film and Process for Producing the Same
11/22/2007	CA2650609A1 Porous metal organic framework based on pyrroles and pyridinones
11/21/2007	EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007	EP1857435A2 A process for the preparation of aryloxypropylamines
11/21/2007	EP1857113A2 Method and materials for treating asthma
11/21/2007	EP1856215A1 Method and use of nanoparticles to bind biocides in paints
11/21/2007	EP1856126A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
11/21/2007	EP1856074A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
11/21/2007	EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007	EP1856043A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
11/21/2007	EP1421062B1 Novel cyclohexyl sulphones
11/21/2007	CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007	CN101076520A Imidazoline derivatives having cb1-antagonistic activity
11/21/2007	CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007	CN101074212A Diphenyl imidazole compound containing fluorine atom
11/20/2007	US7297818 Adamantane derivatives
11/20/2007	US7297794 Phenoxy amine compounds and compositions for delivering active agents
11/20/2007	US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007	US7297708 Central nervous system disorders; psychological disorders
11/20/2007	CA2260926C Illudin analogs useful as antitumor agents
11/20/2007	CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007	WO2007129184A2 An improved process for the preparation of phenytoin sodium
11/15/2007	WO2007084591A3 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid
11/15/2007	WO2007083182A3 Novel heterocycles
11/15/2007	US20070265453 Ionic Liquids Containing Guanidinium Cations
11/15/2007	US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007	US20070265290 Male contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia; prostate cancer
11/15/2007	US20070265250 Imidazole compounds
11/15/2007	US20070265248 Substituted piperazines and methods of use
11/15/2007	US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007	US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/15/2007	CA2654540A1 Histone deacetylase and tubulin deacetylase inhibitors
11/15/2007	CA2651314A1 Hafnium complexes of heterocyclic organic ligands
11/14/2007	EP1853582A2 Heterocyclylamide-substituted imidazoles
11/14/2007	EP1853261A1 Selective inhibitors of human corticosteroid synthases
11/14/2007	EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007	EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007	CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007	CN101070306A Synthesizing method for 1,3, dimethyl-2-imidazolidinone
11/13/2007	US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
11/13/2007	US7294649 Methamphetamine derivatives and conjugates for immunoassay
11/13/2007	US7294644 CB 1 receptor inverse agonists
11/13/2007	US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007	US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007	US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007	CA2398682C Phosphonium and imidazolium salts and methods of their preparation
11/13/2007	CA2248304C Surface modified carbonate materials
11/13/2007	CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007	WO2007126988A2 Selective androgen receptor modulators and methods of use thereof
11/08/2007	WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007	WO2007125197A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007	WO2007125034A2 Mono-nitration of aromatic compounds
11/08/2007	WO2007073503A3 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/08/2007	US20070260066 Process for the Preparation of Telithromycin
11/08/2007	US20070260058 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
11/08/2007	US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007	US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007	DE112005003198T5 Ionische Flüssigkeit Ionic liquid
11/08/2007	CA2665818A1 Therapeutic compounds
11/08/2007	CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007	CA2650385A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007	CA2650035A1 Poly (ethylene glycol) containing chemically disparate endgroups
11/08/2007	CA2648139A1 Diaryl thiohydantoin compounds and their use in the treatment of hyperproliferative disorders
11/07/2007	EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007	EP1852129A1 Remedy for irritable bowel syndrome
11/07/2007	CN101068804A Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
11/07/2007	CN101068791A Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
11/07/2007	CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007	CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007	CN101066951A Prepn process of 2-nitro imido imidazolyl alkane
11/07/2007	CN100347159C Cationic dimeric dyes
11/07/2007	CN100347151C Novel aminobenzoephenones
11/07/2007	CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007	USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007	US7291756 Comprises mixing, kneading a solid host compound and a solid/liquid guest compound by using a kneader and optionally followed by extruding and granulating, holding the product at a temperature above 50; product has improved stability
11/06/2007	US7291752 Production method of β-amino acid
11/06/2007	US7291642 Bradykinin-B1 antagonists, process for their preparation and their use as medicaments
11/06/2007	US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007	US7291621 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide
11/06/2007	US7291609 Specific glucocorticosteroid compound having anti-inflammatory activity

1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 345